RPL26 Human

Ribosomal Protein L26 Human Recombinant
Shipped with Ice Packs
In Stock

Description

UFMylation: A Dynamic Posttranslational Modification

RPL26 is the primary target of UFMylation, a ubiquitin-like modification mediated by the UFM1 conjugation system. Key findings include:

Enzymatic Machinery

EnzymeFunctionRole in RPL26 UFMylationSource
UBA5E1 (activating) enzymeInitiates UFM1 activation
UFC1E2 (conjugating) enzymeTransfers UFM1 to RPL26
UFL1E3 (ligating) enzymeMediates mono- and di-UFMylation
UFSP2De-UFMylation enzymeRemoves UFM1 from RPL26

Mechanism:

  1. Mono-UFMylation occurs at lysine 134 (K134).

  2. Di-UFMylation targets lysine 132 (K132), dependent on prior K134 modification .
    Disruption of UFMylation (e.g., UFSP2 knockout) stabilizes UFMylated RPL26 and impairs ER protein homeostasis .

Regulation of p53 Translation

RPL26 modulates p53 mRNA translation through interactions with the 5’UTR and 3’UTR, forming a double-stranded RNA structure that recruits translation machinery. Key observations:

Mechanistic Insights

ProcessRPL26’s RoleEvidenceSource
Polysome LoadingEnhances p53 mRNA association with ribosomes~2.5-fold increase in translation
MDM2 AntagonismStabilizes p53 by blocking MDM2-mediated degradationRPL26 overexpression increases p53 half-life
Stress ResponseInduces p53 translation post-DNA damageIrradiation triggers RPL26-p53 mRNA binding

Clinical Relevance: Mutations in RPL26 are linked to Diamond-Blackfan Anemia (DBA11), a ribosomopathy characterized by defective erythropoiesis .

Ribosome-Associated Quality Control

RPL26 participates in ER-associated degradation (ERAD) and ribosome quality control (RQC) pathways:

ER-RQC Pathway

ComponentFunctionImpact of RPL26 UFMylation DefectSource
ER-APsER-associated aberrant proteinsAccumulate in UFC1/UFL1 KO cells
Ribosome StallingTriggers UFMylated RPL26 recruitmentRequired for ER-AP degradation

UFMylation Dependency: RPL26ΔC (lacking UFMylation sites) fails to support ER-RQC, leading to ER stress .

Tom1/Huwe1-Mediated Degradation

In yeast and humans, excess RPL26 is degraded via Tom1 (yeast) or Huwe1 (human), E3 ligases that ubiquitinate unassembled ribosomal proteins . This pathway prevents proteotoxic stress but is bypassed in ribosomopathies .

Diamond-Blackfan Anemia (DBA11)

Mutation TypePhenotypeMechanismSource
RPL26 MutationsHypoplastic anemia, bone marrow failureImpaired ribosome biogenesis
C-Terminal DeletionsLoss of UFMylation sitesDisrupted ER protein homeostasis

Genetic Data: LOVD reports 5 public variants, including a frameshift mutation (c.325delC) linked to DBA .

Cancer and Stress Response

RPL26 overexpression enhances p53-mediated apoptosis, suggesting a tumor-suppressive role . Conversely, its downregulation may contribute to cancer progression .

Recombinant Protein

PropertySpecificationSource
SourceE. coli (His-tagged)
Purity>85%
ApplicationsWestern blot, MS, ER-RQC assays

CRISPR Knockout Models

  • RPL26ΔC: Lacks UFMylation sites (K132R/K134R), used to study ER-RQC defects .

  • UFM1 KO/UBA5 KO: Cell lines to dissect UFMylation dependencies .

Product Specs

Introduction
Ribosomal Protein L26, abbreviated as RPL26, is a protein found within ribosomes. It is specifically located in the larger of the two ribosomal subunits, known as the 60S subunit. This protein belongs to a family of ribosomal proteins called the L24P family and resides in the cytoplasm of the cell. Like many genes encoding ribosomal proteins, there are multiple non-functional copies of the RPL26 gene, known as pseudogenes, scattered throughout the genome.
Description
This product consists of the human RPL26 protein, manufactured in the bacterium E. coli. It is a single chain of 168 amino acids, with the first 145 amino acids forming the RPL26 protein itself. A 23 amino acid His-tag is attached to the start of the protein sequence (N-terminus). The molecular weight of the resulting protein is 19.6kDa. This recombinant RPL26 protein has been purified using specialized chromatographic methods.
Physical Appearance
A clear solution, free from any particles, that has been sterilized by filtration.
Formulation
The RPL26 is provided in a solution containing 0.25mg of protein per milliliter. The solution also contains 20mM Tris-HCl buffer with a pH of 8.0, 0.15M NaCl, 40% glycerol, and 1mM DTT.
Stability
For short-term storage (2-4 weeks), the product can be kept at a refrigerated temperature of 4°C. For extended storage, it is recommended to freeze the product at -20°C. To ensure the product's stability during long-term storage, consider adding a carrier protein like HSA or BSA at a concentration of 0.1%. It's important to avoid repeatedly freezing and thawing the product.
Purity
The purity of this product is greater than 85%, as determined by SDS-PAGE analysis.
Synonyms
L26, Ribosomal Protein L26, 60S Ribosomal Protein L26.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSMKFNPFV TSDRSKNRKR HFNAPSHIRR KIMSSPLSKE LRQKYNVRSM PIRKDDEVQV VRGHYKGQQI GKVVQVYRKK YVIYIERVQR EKANGTTVHV GIHPSKVVIT RLKLDKDRKK ILERKAKSRQ VGKEKGKYKE ETIEKMQE.

Q&A

What is RPL26 and what is its primary function in human cells?

RPL26 is a component of the large ribosomal subunit (60S) and belongs to the universal ribosomal protein uL24 family. It functions primarily as part of the ribosome, the large ribonucleoprotein complex responsible for protein synthesis in cells . The full-length human RPL26 protein consists of 145 amino acids and plays essential roles in ribosome assembly and function. Beyond its structural role in the ribosome, RPL26 has been identified as a regulatory protein involved in translation control of specific mRNAs and in cellular stress response pathways .

What is the relationship between RPL26 and p73 regulation?

RPL26 has been demonstrated to regulate the expression of p73, a p53 family member with tumor suppressor functions. This regulation occurs at multiple levels, with the most significant impact being post-transcriptional. Studies have shown that RPL26 knockdown decreases TAp73 protein levels in various cell lines including HCT116, p53-/- HCT116, and SW480 cells, while ectopic expression of RPL26 increases TAp73 protein levels . Interestingly, this regulation occurs without significant alterations in p73 transcript levels, indicating that RPL26 primarily affects p73 expression at the translational or post-translational level .

How does RPL26 impact protein translation beyond its structural role?

RPL26 directly influences translation of specific mRNAs through several mechanisms. It has been shown to bind directly to the 3' untranslated region (3'UTR) of p73 mRNA . Additionally, RPL26 interacts with the cap-binding protein eIF4E, enhancing the association of eIF4E with target mRNAs like p73, thereby promoting their translation . Polysome profiling experiments demonstrate that RPL26 is necessary for efficient assembly of polysomes on p73 mRNA, further confirming its role in translation regulation beyond mere structural support in the ribosome .

What are the most effective approaches for modulating RPL26 expression in experimental systems?

For RPL26 knockdown, siRNA transfection has proven effective across multiple cell lines. Studies utilizing two distinct siRNAs targeting RPL26 have demonstrated significant reduction in RPL26 protein levels within 72 hours post-transfection . For overexpression studies, transient transfection with expression vectors encoding RPL26 has been successfully employed in various cell lines including SW480, HCT116, and H1299 . When designing these experiments, appropriate controls are crucial - scrambled siRNAs for knockdown studies and empty vectors for overexpression experiments to account for transfection-related effects.

How can researchers effectively assess RPL26's impact on target protein expression?

A multi-faceted approach is recommended:

TechniquePurposeKey Considerations
Western blottingProtein level quantificationUse validated antibodies; include loading controls
qRT-PCRTranscript level analysisMultiple reference genes; primer efficiency validation
35S-metabolic labelingDe novo protein synthesisShort labeling periods (30-60 min); careful normalization
Polysome profilingmRNA translation efficiencyGradient quality; RNA integrity during fractionation
Half-life determinationProtein stability assessmentCycloheximide concentration; timepoints selection

Particularly informative is the combination of protein and mRNA quantification to distinguish between transcriptional and post-transcriptional regulation mechanisms .

What methodologies are recommended for studying RPL26-RNA interactions?

RNA immunoprecipitation followed by RT-PCR (RNA-ChIP) has been successfully employed to demonstrate direct interaction between RPL26 and target mRNAs . This approach involves immunoprecipitation of RPL26-containing complexes followed by RNA extraction and RT-PCR detection of associated transcripts. RNA electrophoretic mobility shift assays (REMSA) provide complementary evidence by detecting direct binding of purified RPL26 to RNA fragments, allowing mapping of specific binding sites within target transcripts . When performing these experiments, inclusion of appropriate negative controls (IgG immunoprecipitation, non-target transcripts) is essential for result interpretation.

How does RPL26 participate in endoplasmic reticulum stress responses?

RPL26 undergoes ufmylation (a ubiquitin-like modification) by UFL1 in response to endoplasmic reticulum stress . This post-translational modification promotes reticulophagy of endoplasmic reticulum sheets, an important quality control mechanism for maintaining ER homeostasis . This finding connects RPL26 to cellular stress adaptation pathways beyond its canonical role in ribosome function. Researchers investigating this aspect should consider employing inducers of ER stress such as tunicamycin or thapsigargin and monitoring both RPL26 ufmylation status and markers of reticulophagy.

What is the functional significance of RPL26 in the MDM2-p73 regulatory axis?

RPL26 modulates p73 protein stability partly through interaction with MDM2, an E3 ubiquitin ligase known to target p73 for degradation . Experiments with MDM2-knockout cell lines demonstrate that the basal level of TAp73 protein is significantly higher than in isogenic control cells, confirming MDM2's role in regulating p73 stability . Interestingly, RPL26 can still regulate p73 expression in MDM2-knockout cells, albeit to a lesser extent, suggesting multiple regulatory mechanisms . This complex interplay has implications for cellular stress responses, as p73 is an important mediator of apoptosis and cell cycle arrest under various stress conditions.

How can researchers differentiate between RPL26's ribosomal and extra-ribosomal functions?

This remains challenging but several approaches can help:

  • Mutational analysis: Generating RPL26 variants that maintain structural integrity but affect specific interactions

  • Subcellular fractionation: Distinguishing ribosome-bound versus free RPL26 pools

  • Polysome analysis: Comparing global translation versus specific mRNA translation effects

  • Temporal studies: Analyzing rapid responses that occur before global translation changes

When interpreting results, researchers should consider that these functions are likely interconnected, with ribosomal perturbations potentially triggering extra-ribosomal activities and vice versa .

What methodological approaches are recommended for studying RPL26's role in polysome assembly?

Sucrose density gradient centrifugation provides valuable insights into polysome formation and can be applied to cells with modulated RPL26 expression. Studies have shown that RPL26 knockdown affects the distribution of specific mRNAs like TAp73 across polysome fractions . When conducting these experiments, researchers should:

  • Optimize lysis conditions to preserve polysome integrity

  • Include appropriate controls (EDTA treatment disrupts polysomes)

  • Analyze multiple mRNAs (targets and non-targets) to differentiate specific effects

  • Quantify relative mRNA abundance across fractions using RT-qPCR

  • Consider polysome:monosome ratios as indicators of translation efficiency

These approaches have revealed that RPL26 is necessary for proper assembly of polysomes on TAp73 mRNA, supporting its role in translation regulation .

How can contradictory results between RPL26 protein levels and functional outcomes be reconciled?

Researchers should consider several factors when interpreting seemingly contradictory results:

  • RPL26 may have threshold effects rather than linear dose-dependent activity

  • Post-translational modifications may alter RPL26 function independently of total protein levels

  • Cell-type specific factors may influence RPL26 activity

  • RPL26's integration into ribosomes versus its free pool may have distinct functions

  • Feedback mechanisms may compensate for altered RPL26 expression

A comprehensive approach combining quantitative protein analysis, functional assays, and examination of relevant pathways is recommended to resolve apparent contradictions .

What is known about the structural determinants of RPL26 interactions with RNA?

While the complete structural basis remains under investigation, RPL26 directly binds to the 3'UTR of target mRNAs such as p73 . The protein's ability to enhance association between eIF4E and target mRNAs suggests potential involvement in RNA secondary structure remodeling or recruitment of translation initiation factors . For researchers investigating these interactions, approaches such as deletion mapping, site-directed mutagenesis, and structural studies (X-ray crystallography or cryo-EM) of RPL26-RNA complexes would provide valuable insights into the molecular determinants of specificity and affinity.

What are common pitfalls in RPL26 knockdown experiments and how can they be addressed?

Several challenges may arise in RPL26 depletion studies:

How can researchers distinguish direct versus indirect effects of RPL26 on target gene expression?

This distinction requires multiple complementary approaches:

  • Direct binding assays: RNA-ChIP and REMSA to demonstrate physical interaction between RPL26 and target mRNAs .

  • Rapid response analysis: Examining effects shortly after RPL26 modulation before secondary changes occur.

  • Rescue experiments: Introducing RPL26 variants with mutations in specific domains to identify regions required for target regulation.

  • Heterologous reporter systems: Using constructs with target mRNA regulatory regions (e.g., 3'UTR) fused to reporter genes to isolate direct effects .

  • In vitro translation: Reconstituting the regulatory effect using purified components to demonstrate direct mechanism.

What emerging areas of RPL26 research warrant further investigation?

Several promising research directions include:

  • Comprehensive identification of RPL26-regulated mRNAs beyond p73 using techniques like CLIP-seq

  • Investigation of RPL26 post-translational modifications beyond ufmylation and their functional consequences

  • Exploration of RPL26's role in cellular stress responses beyond ER stress

  • Examination of potential RPL26 dysregulation in human diseases, particularly cancer

  • Development of tools to specifically modulate extra-ribosomal functions without affecting ribosome assembly

These areas represent significant knowledge gaps where new insights could advance understanding of ribosomal protein biology beyond structural roles .

What experimental approaches might reveal novel aspects of RPL26 function?

Emerging technologies offer new opportunities for RPL26 research:

  • Proximity labeling techniques (BioID, APEX) to identify novel RPL26 interaction partners in different cellular compartments

  • Single-molecule imaging to track RPL26 dynamics during stress responses

  • CRISPR-based screens to identify genetic interactions with RPL26

  • Ribosome profiling to comprehensively assess RPL26's impact on translation at the genome-wide level

  • Cryo-electron microscopy to define structural roles of RPL26 in specialized ribosomes

Implementation of these approaches could reveal unexpected functions and regulatory mechanisms of this multifaceted ribosomal protein .

Product Science Overview

Introduction

Ribosomal Protein L26 (RPL26) is a crucial component of the ribosome, specifically part of the large 60S subunit. Ribosomes are essential organelles responsible for protein synthesis in cells. The human recombinant version of RPL26 is produced using recombinant DNA technology, which allows for the expression of the protein in a host organism, such as E. coli.

Structure and Function

RPL26 belongs to the L24P family of ribosomal proteins and is located in the cytoplasm . The protein consists of 145 amino acids and has a molecular weight of approximately 19.6 kDa . It plays a vital role in the assembly and function of the ribosome, contributing to the translation of mRNA into proteins .

Biological Significance

RPL26 is involved in several critical cellular processes:

  • Protein Synthesis: As a structural constituent of the ribosome, RPL26 is directly involved in the translation process, facilitating the synthesis of proteins .
  • DNA Damage Response: RPL26 has been shown to increase the translation of p53 mRNA by binding to its 5’ untranslated region (UTR) after DNA damage . This enhances the cellular response to DNA damage and helps maintain genomic stability.
  • Regulation of Apoptosis: RPL26 is implicated in the regulation of apoptosis, particularly in response to DNA damage. It positively regulates the intrinsic apoptotic signaling pathway mediated by p53 .
Recombinant Production

The human recombinant RPL26 is typically produced in E. coli and purified using conventional chromatography techniques . The recombinant protein often includes an N-terminal His-tag to facilitate purification and detection. The production process ensures high purity and functionality of the protein, making it suitable for various research applications.

Applications in Research

Recombinant RPL26 is widely used in biochemical and molecular biology research. Some of its applications include:

  • Structural Studies: Understanding the structure and function of ribosomal proteins.
  • Functional Assays: Investigating the role of RPL26 in protein synthesis and cellular responses to DNA damage.
  • Drug Development: Exploring potential therapeutic targets for diseases related to ribosomal dysfunction and DNA damage response.
Related Diseases

Mutations or dysregulation of RPL26 have been associated with certain diseases, such as Diamond-Blackfan Anemia, a rare genetic disorder characterized by failure to produce red blood cells . Understanding the function and regulation of RPL26 can provide insights into the pathogenesis of such diseases and aid in the development of targeted therapies.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.